V Witko-Sarsat, C Delacourt, D Rabier, J Bardet, AT Nguyen and B Descamps-Latscha
INSERM U25, Hopital Necker, Paris, France.

We evaluated long-lived oxidant potential in the sputum of patients with cystic fibrosis (CF) by quantitating the methionine-inhibitable, long-lived oxidant fraction of sputum, referred to as the chloramines. Taurine, the preferred amino acid substrate for chloramine formation, and myeloperoxidase (MPO), the chlorinated oxidant-generating enzyme, were also quantitated. As compared with the sputum of asthmatic subjects, the sputum of CF patients contained high concentrations of chloramines along with high levels of taurine and active MPO. A negative correlation between chloramine and taurine was found in the sputum of CF patients. No correlation was found between the density of Pseudomonas aeruginosa and the level of chloramines, taurine, or MPO. In contrast, respiratory parameters (%FEV or %FVC) and a nutritional index correlated positively with chloramine levels, whereas negative correlations were observed with taurine and MPO. In addition, the effect of antibiotic therapy, which significantly increased chloramine and decreased taurine levels, supported a beneficial effect of chloramines on overall clinical status. Our findings support a dual role of long-lived oxidants at the site of airway inflammation in CF, one component of which is their ability to mediate oxidative stress and the other a beneficial effect that may be partly explained by their inhibitory effect on antiprotease defense systems.

This article has been cited by other articles:

				D G Downey, S C Bell, and J S Elborn Neutrophils in cystic fibrosis Thorax, January 1, 2009; 64(1): 81 - 88. [Abstract] [Full Text] [PDF]

				C. Kariya, H. Leitner, E. Min, C. van Heeckeren, A. van Heeckeren, and B. J. Day A role for CFTR in the elevation of glutathione levels in the lung by oral glutathione administration Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1590 - L1597. [Abstract] [Full Text] [PDF]

				A. Krasniak, M. Drozdz, M. Pasowicz, G. Chmiel, M. Michalek, D. Szumilak, P. Podolec, P. Klimeczek, M. Konieczynska, E. Wicher-Muniak, et al. Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients Nephrol. Dial. Transplant., February 1, 2007; 22(2): 515 - 521. [Abstract] [Full Text] [PDF]

				E. F. McKone, J. Shao, D. D. Frangolias, C. L. Keener, C. A. Shephard, F. M. Farin, M. R. Tonelli, P. D. Pare, A. J. Sandford, M. L. Aitken, et al. Variants in the Glutamate-Cysteine-Ligase Gene Are Associated with Cystic Fibrosis Lung Disease Am. J. Respir. Crit. Care Med., August 15, 2006; 174(4): 415 - 419. [Abstract] [Full Text] [PDF]

				A. M. Cantin, G. Bilodeau, C. Ouellet, J. Liao, and J. W. Hanrahan Oxidant stress suppresses CFTR expression Am J Physiol Cell Physiol, January 1, 2006; 290(1): C262 - C270. [Abstract] [Full Text] [PDF]

				H. Zhou, F. Lu, C. Latham, D. S. Zander, and G. A. Visner Heme Oxygenase-1 Expression in Human Lungs with Cystic Fibrosis and Cytoprotective Effects against Pseudomonas Aeruginosa In Vitro Am. J. Respir. Crit. Care Med., September 15, 2004; 170(6): 633 - 640. [Abstract] [Full Text] [PDF]

				B. J. Day, A. M. van Heeckeren, E. Min, and L. W. Velsor Role for Cystic Fibrosis Transmembrane Conductance Regulator Protein in a Glutathione Response to Bronchopulmonary Pseudomonas Infection Infect. Immun., April 1, 2004; 72(4): 2045 - 2051. [Abstract] [Full Text] [PDF]

				C. H. Goss, S. A. Newsom, J. S. Schildcrout, L. Sheppard, and J. D. Kaufman Effect of Ambient Air Pollution on Pulmonary Exacerbations and Lung Function in Cystic Fibrosis Am. J. Respir. Crit. Care Med., April 1, 2004; 169(7): 816 - 821. [Abstract] [Full Text] [PDF]

				M. Griese, J. Ramakers, A. Krasselt, V. Starosta, S. van Koningsbruggen, R. Fischer, F. Ratjen, B. Mullinger, R. M. Huber, K. Maier, et al. Improvement of Alveolar Glutathione and Lung Function but Not Oxidative State in Cystic Fibrosis Am. J. Respir. Crit. Care Med., April 1, 2004; 169(7): 822 - 828. [Abstract] [Full Text] [PDF]

				V. De Rose Mechanisms and markers of airway inflammation in cystic fibrosis Eur. Respir. J., February 1, 2002; 19(2): 333 - 340. [Abstract] [Full Text] [PDF]

				J. Cortijo, M. Cerda-Nicolas, A. Serrano, G. Bioque, J.M. Estrela, F. Santangelo, A. Esteras, A. Llombart-Bosch, and E.J. Morcillo Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats Eur. Respir. J., June 1, 2001; 17(6): 1228 - 1235. [Abstract] [Full Text] [PDF]

				Q.-L. Ying and S. R. Simon DNA from Bronchial Secretions Modulates Elastase Inhibition by alpha 1-Proteinase Inhibitor and Oxidized Secretory Leukoprotease Inhibitor Am. J. Respir. Cell Mol. Biol., October 1, 2000; 23(4): 506 - 513. [Abstract] [Full Text]

				M. Nagl, M. W. Hess, K. Pfaller, P. Hengster, and W. Gottardi Bactericidal Activity of Micromolar N-Chlorotaurine: Evidence for Its Antimicrobial Function in the Human Defense System Antimicrob. Agents Chemother., September 1, 2000; 44(9): 2507 - 2513. [Abstract] [Full Text]

				A. Van der Vliet, M. N. Nguyen, M. K. Shigenaga, J. P. Eiserich, G. P. Marelich, and C. E. Cross Myeloperoxidase and protein oxidation in cystic fibrosis Am J Physiol Lung Cell Mol Physiol, September 1, 2000; 279(3): L537 - L546. [Abstract] [Full Text] [PDF]

				P. PAREDI, S. A. KHARITONOV, D. LEAK, P. L. SHAH, D. CRAMER, M. E. HODSON, and P. J. BARNES Exhaled Ethane Is Elevated in Cystic Fibrosis and Correlates with Carbon Monoxide Levels and Airway Obstruction Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1247 - 1251. [Abstract] [Full Text]

				P. Montuschi, S. A Kharitonov, G. Ciabattoni, M. Corradi, L. van Rensen, D. M Geddes, M. E Hodson, and P. J Barnes Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis Thorax, March 1, 2000; 55(3): 205 - 209. [Abstract] [Full Text]

				K. Takeyama, K. Dabbagh, J. Jeong Shim, T. Dao-Pick, I. F. Ueki, and J. A. Nadel Oxidative Stress Causes Mucin Synthesis Via Transactivation of Epidermal Growth Factor Receptor: Role of Neutrophils J. Immunol., February 1, 2000; 164(3): 1546 - 1552. [Abstract] [Full Text] [PDF]

				P Paredi, P L Shah, P Montuschi, P Sullivan, M E Hodson, S A Kharitonov, and P J Barnes Increased carbon monoxide in exhaled air of patients with cystic fibrosis Thorax, October 1, 1999; 54(10): 917 - 920. [Abstract] [Full Text]

				S. W. STITES, M. W. PLAUTZ, K. BAILEY, A. R. O'BRIEN-LADNER, and L. J. WESSELIUS Increased Concentrations of Iron and Isoferritins in the Lower Respiratory Tract of Patients with Stable Cystic Fibrosis Am. J. Respir. Crit. Care Med., September 1, 1999; 160(3): 796 - 801. [Abstract] [Full Text]

				V. Witko-Sarsat, L. Halbwachs-Mecarelli, A. Schuster, P. Nusbaum, I. Ueki, S. Canteloup, G. Lenoir, B. Descamps-Latscha, and J. A. Nadel Proteinase 3, a Potent Secretagogue in Airways, Is Present in Cystic Fibrosis Sputum Am. J. Respir. Cell Mol. Biol., April 1, 1999; 20(4): 729 - 736. [Abstract] [Full Text]

				S. J. LINNANE, V. M. KEATINGS, C. M. COSTELLO, J. B. MOYNIHAN, C. M. O'CONNOR, M. X. FITZGERALD, and P. MCLOUGHLIN Total Sputum Nitrate plus Nitrite Is Raised during Acute Pulmonary Infection in Cystic Fibrosis Am. J. Respir. Crit. Care Med., July 1, 1998; 158(1): 207 - 212. [Abstract] [Full Text] [PDF]

				Z.E. Suntres and P.N. Shek {alpha}-Tocopherol liposomes alleviate LPS-induced hepatotoxicities Innate Immunity, December 1, 1996; 3(6): 505 - 512. [Abstract] [PDF]